Bronchiectasis.ppt
•Download as PPT, PDF•
1 like•141 views
This document discusses bronchiectasis, which is the abnormal dilatation of the bronchi. It can be caused by congenital issues, infections, or other lung diseases. People with bronchiectasis experience a chronic cough with large amounts of sputum, as well as recurrent lung infections and damage. Diagnosis involves imaging tests and sputum cultures. Treatment focuses on airway clearance through physiotherapy, use of bronchodilators and antibiotics to treat infections, and sometimes surgery. Managing the underlying cause is important to prevent progression and improve prognosis.
Report
Share
Report
Share
Recommended
Bronchiectasis
Bronchiectasis is a chronic lung condition defined by abnormal dilatation of the bronchi. It can be caused by infections, genetic conditions, or other lung diseases that damage the airways. People with bronchiectasis commonly produce large amounts of sputum and experience recurrent lung infections. Diagnosis is made through chest imaging like CT scans. Treatment focuses on airway clearance and controlling infections with antibiotics. Surgical options are available for severe cases involving hemorrhage or localized disease.
Chronic Bronchitis
Shahd Alali has chronic bronchitis, characterized by a chronic cough lasting over 2 years. Chronic bronchitis is common among smokers and is caused by smoking as well as air pollutants. It involves hypertrophy of the bronchial mucus glands leading to hypersecretion of mucus and inflammation in the large airways. On morphology, the large airways appear hyperemic, swollen, and covered in mucus secretions with increased goblet cells and inflammatory cells in the trachea and bronchi. Clinical features include a prominent cough producing sputum, cyanosis, increased risk of infection, and dyspnea.
Pulmonary edema
Pulmonary edema is fluid accumulation in the lungs caused by fluid leaking from blood vessels into the lung tissue and air spaces. It can be caused by issues that increase pressure in the blood vessels of the lungs like heart failure, or by problems that damage the blood vessel walls. Symptoms include shortness of breath, cough, and anxiety. Treatment depends on the underlying cause but aims to reduce fluid buildup and support breathing. Differentiating cardiogenic from non-cardiogenic pulmonary edema involves considering medical history, symptoms, physical exam findings, and chest imaging results.
Emphysema
Emphysema is a lung disease characterized by abnormal enlargement of the air spaces in the lungs. There are several types of emphysema including centriacinar, panacinar, distal acinar, and irregular emphysema. The main pathogenesis involves an imbalance between protease enzymes like elastase released by smoke exposure and antioxidant proteins like alpha-1 antitrypsin that normally inhibit these enzymes. This imbalance leads to destruction of lung elastic tissue and enlargement of the air spaces. Patients may present as "pink puffers" with barrel chests and prolonged expiration or "blue bloaters" with hypoxia and cor pulmonale. Diagnosis involves spirometry showing reduced FEV1 and imaging
Respiratory failure
This document provides an overview of respiratory failure, including its causes, types, symptoms, diagnosis, and management. It begins by defining respiratory failure as the failure of the respiratory system in gas exchange functions of oxygenation and carbon dioxide elimination. Respiratory failure is then classified based on PaO2 and PaCO2 levels into hypoxemic (Type I) and hypercapnic (Type II) types. Common causes, clinical features, investigations, and general management principles are discussed for respiratory failure. Key aspects of managing hypoxemia and hypercapnia are also summarized.
Management of Respiratory Failure
This document discusses respiratory failure, defined as inadequate oxygenation, ventilation, or both to meet metabolic demands. It can be classified as type 1 (hypoxemic) or type 2 (hypercapnic) respiratory failure. Risk factors include age, smoking, lung disease, and neurological or muscular disorders. Pathophysiology involves ventilation-perfusion mismatching, right-to-left shunting, or hypoventilation. Causes include pneumonia, pulmonary embolism, neuromuscular disorders, and acute respiratory distress syndrome. The control of breathing and gas exchange physiology are also summarized.
Interstitial lung diseases
1. Interstitial lung diseases (ILDs) involve the lung parenchyma including the alveoli, capillaries, and spaces between.
2. ILDs are classified based on known causes, idiopathic forms, and granulomatous types. Idiopathic pulmonary fibrosis is the most common idiopathic form.
3. Clinical presentation involves breathlessness, cough, and reduced lung function. Investigations include chest imaging showing infiltrates and fibrosis, and lung biopsies to determine classification. Treatment focuses on removing exposures, suppressing inflammation, and palliating symptoms primarily using corticosteroids.
Respiratory failure
This document discusses respiratory failure, including its definition, types, causes, clinical manifestations, diagnostic evaluations, management, and complications. Respiratory failure is when the respiratory system fails to adequately oxygenate the blood or eliminate carbon dioxide. It can be classified as hypoxemic or hypercapnic. Acute respiratory failure develops rapidly over hours while chronic develops over days. Management involves treating the underlying cause, providing oxygen supplementation, monitoring vital signs, and supporting respiratory function. Complications can affect the lungs, heart, gastrointestinal system, and risk of infection.
Recommended
Bronchiectasis
Bronchiectasis is a chronic lung condition defined by abnormal dilatation of the bronchi. It can be caused by infections, genetic conditions, or other lung diseases that damage the airways. People with bronchiectasis commonly produce large amounts of sputum and experience recurrent lung infections. Diagnosis is made through chest imaging like CT scans. Treatment focuses on airway clearance and controlling infections with antibiotics. Surgical options are available for severe cases involving hemorrhage or localized disease.
Chronic Bronchitis
Shahd Alali has chronic bronchitis, characterized by a chronic cough lasting over 2 years. Chronic bronchitis is common among smokers and is caused by smoking as well as air pollutants. It involves hypertrophy of the bronchial mucus glands leading to hypersecretion of mucus and inflammation in the large airways. On morphology, the large airways appear hyperemic, swollen, and covered in mucus secretions with increased goblet cells and inflammatory cells in the trachea and bronchi. Clinical features include a prominent cough producing sputum, cyanosis, increased risk of infection, and dyspnea.
Pulmonary edema
Pulmonary edema is fluid accumulation in the lungs caused by fluid leaking from blood vessels into the lung tissue and air spaces. It can be caused by issues that increase pressure in the blood vessels of the lungs like heart failure, or by problems that damage the blood vessel walls. Symptoms include shortness of breath, cough, and anxiety. Treatment depends on the underlying cause but aims to reduce fluid buildup and support breathing. Differentiating cardiogenic from non-cardiogenic pulmonary edema involves considering medical history, symptoms, physical exam findings, and chest imaging results.
Emphysema
Emphysema is a lung disease characterized by abnormal enlargement of the air spaces in the lungs. There are several types of emphysema including centriacinar, panacinar, distal acinar, and irregular emphysema. The main pathogenesis involves an imbalance between protease enzymes like elastase released by smoke exposure and antioxidant proteins like alpha-1 antitrypsin that normally inhibit these enzymes. This imbalance leads to destruction of lung elastic tissue and enlargement of the air spaces. Patients may present as "pink puffers" with barrel chests and prolonged expiration or "blue bloaters" with hypoxia and cor pulmonale. Diagnosis involves spirometry showing reduced FEV1 and imaging
Respiratory failure
This document provides an overview of respiratory failure, including its causes, types, symptoms, diagnosis, and management. It begins by defining respiratory failure as the failure of the respiratory system in gas exchange functions of oxygenation and carbon dioxide elimination. Respiratory failure is then classified based on PaO2 and PaCO2 levels into hypoxemic (Type I) and hypercapnic (Type II) types. Common causes, clinical features, investigations, and general management principles are discussed for respiratory failure. Key aspects of managing hypoxemia and hypercapnia are also summarized.
Management of Respiratory Failure
This document discusses respiratory failure, defined as inadequate oxygenation, ventilation, or both to meet metabolic demands. It can be classified as type 1 (hypoxemic) or type 2 (hypercapnic) respiratory failure. Risk factors include age, smoking, lung disease, and neurological or muscular disorders. Pathophysiology involves ventilation-perfusion mismatching, right-to-left shunting, or hypoventilation. Causes include pneumonia, pulmonary embolism, neuromuscular disorders, and acute respiratory distress syndrome. The control of breathing and gas exchange physiology are also summarized.
Interstitial lung diseases
1. Interstitial lung diseases (ILDs) involve the lung parenchyma including the alveoli, capillaries, and spaces between.
2. ILDs are classified based on known causes, idiopathic forms, and granulomatous types. Idiopathic pulmonary fibrosis is the most common idiopathic form.
3. Clinical presentation involves breathlessness, cough, and reduced lung function. Investigations include chest imaging showing infiltrates and fibrosis, and lung biopsies to determine classification. Treatment focuses on removing exposures, suppressing inflammation, and palliating symptoms primarily using corticosteroids.
Respiratory failure
This document discusses respiratory failure, including its definition, types, causes, clinical manifestations, diagnostic evaluations, management, and complications. Respiratory failure is when the respiratory system fails to adequately oxygenate the blood or eliminate carbon dioxide. It can be classified as hypoxemic or hypercapnic. Acute respiratory failure develops rapidly over hours while chronic develops over days. Management involves treating the underlying cause, providing oxygen supplementation, monitoring vital signs, and supporting respiratory function. Complications can affect the lungs, heart, gastrointestinal system, and risk of infection.
Cystic Lung Diseases
The document provides an overview of cystic lung diseases and discusses a systematic approach to evaluating cystic lung lesions on CT scans. It begins by defining pulmonary cysts and differentiating them from cavities. It then categorizes cysts based on their location, number, distribution, and associated CT findings. The document outlines a 5-question approach to systematically evaluate cystic lung lesions: 1) Are they true cysts? 2) Are cysts subpleural? 3) Are cysts solitary or multifocal without other findings? 4) Are cysts associated with nodules? 5) Are cysts associated with ground glass opacities? It then provides examples of specific diseases that present with various cyst patterns, such as
Ppt atelectasis
Atelectasis is a collapse or closure of the alveoli in the lungs resulting in reduced or absent ventilation of those areas. It can be caused by obstruction of the airways or pressure on the outside of the lungs. Risk factors include recent surgery, lung disease, premature birth, or confinement to bed. Symptoms include shortness of breath, cough, and low oxygen levels. Treatment focuses on resolving the underlying cause and techniques to reopen the collapsed areas such as bronchodilators, chest physiotherapy, positioning, and sometimes surgery. Nursing care involves monitoring breathing and oxygen levels, encouraging deep breathing and coughing exercises, and preventing complications like pneumonia.
Bronchiectasis
Bronchiectasis in children is an irreversible dilation of the airways caused by destructive changes to the airway walls. It has many causes including cystic fibrosis, infections, immunodeficiencies, and anatomical defects. The pathology involves a vicious cycle of impaired mucus clearance leading to recurrent infections, inflammation, and further airway damage. Symptoms include cough, sputum production, and breathing difficulties. Diagnosis is made through imaging like HRCT that shows changes to airway contours. Treatment focuses on airway clearance techniques and controlling infections with antibiotics. Management of underlying conditions and lung transplantation may be needed in severe cases.
Pulmonary fibrosis
Pulmonary fibrosis involves the replacement of lung tissue by fibrous tissue, reducing lung volume and altering texture so that ventilation cannot take place. It increases lung recoil pressure and work of breathing. There are three main types: replacement, focal, and interstitial fibrosis. Idiopathic pulmonary fibrosis (IPF) is a disorder of unknown cause characterized by bilateral, progressive interstitial fibrosis with a histological pattern of usual interstitial pneumonia. It typically affects older adults and has a poor prognosis. Symptoms include a dry cough and dyspnea. Investigations show reticulation on chest imaging and restrictive lung function. Treatment is difficult and lung transplantation is the only definitive option.
Lung abscess
This document discusses lung abscesses, which occur when microbial infection causes necrosis and cavitation of lung tissue. There are two main types: primary lung abscesses arise from aspiration of oral bacteria and usually affect middle-aged men with risk factors like alcoholism or gastroesophageal reflux; secondary lung abscesses have an underlying cause like obstruction or immunosuppression. Symptoms include fever, cough, and chest pain. Diagnosis involves chest imaging like x-ray or CT scan. Primary abscesses are generally treated with antibiotics like clindamycin or beta-lactam combinations for 3-14 weeks. Secondary abscesses require treatment of the underlying condition as well as antibiotics targeting the identified pathogen. Complications can include recurrence,
Pneumothorax
This document discusses pneumothorax, beginning with a definition and overview of types including spontaneous, traumatic, and tension pneumothorax. Risk factors are identified such as male sex, smoking, age, genetics, and lung disease. Diagnosis involves physical exam findings and imaging tests like chest x-ray and CT scan. Treatment goals are promoting lung expansion and eliminating causes, using methods such as aspiration, tube drainage, or surgery. Complications are also reviewed.
atelectasis
Atelectasis is the collapse or closure of part or all of the lung resulting in reduced gas exchange. It can be primary, due to prematurity or lung immaturity, or secondary due to obstruction from mucus, tumors, or surgery. Symptoms include rapid shallow breathing, cough, hypoxia, and fever. Diagnosis involves chest x-ray, sputum tests, and CT scans. Treatment focuses on positioning, suctioning mucus, oxygen therapy, and preventing infections. Nursing care manages breathing, airway clearance, gas exchange, and monitors for complications like infections.
13 respiratory failure
The document discusses respiratory failure, including its definition, classification, causes, mechanisms, clinical manifestations, diagnosis and treatment. It defines respiratory failure as a clinical syndrome caused by conditions severely affecting the lung's ability to oxygenate blood or eliminate carbon dioxide. Treatment involves identifying and managing the underlying cause, ensuring an open airway, providing oxygen therapy, and mechanical ventilation if needed.
Chronic bronchitis
Chronic bronchitis is defined as a persistent cough with mucus production for at least three months in a year for two consecutive years. It is primarily caused by long-term irritation and inflammation of the airways due to cigarette smoke or other inhaled chemicals. Chronic bronchitis can progress to more severe lung diseases like COPD or lung cancer and, if left untreated, may result in heart failure or respiratory infections. The pathology involves damage to the airways, thickening of the mucus membranes, and increased mucus production.
Respiratory failure
Respiratory failure occurs when the lungs fail to effectively oxygenate the blood or remove carbon dioxide. It is classified as type 1 (hypoxic but normal CO2 levels) or type 2 (hypoxic and elevated CO2 levels). Type 1 is more common and caused by conditions like pneumonia that affect only part of the lungs. Type 2 involves more generalized lung damage. Acute respiratory failure develops rapidly while chronic failure progresses over days or longer. Treatment depends on the underlying cause but may include supplemental oxygen, mechanical ventilation, treating infection, or lung transplantation in severe cases.
Copd 2012 pdf
This document discusses chronic obstructive pulmonary disease (COPD). It defines COPD as a common lung disease characterized by persistent airflow limitation. The document covers COPD epidemiology, risk factors, pathology, clinical features, investigations, management, and treatment options. Management involves smoking cessation, bronchodilators, inhaled corticosteroids, vaccinations, oxygen therapy, and pulmonary rehabilitation.
Emphysema ppt
Emphysema is a lung disease that causes damage to the air sacs in the lungs called alveoli, resulting in shortness of breath. It is usually caused by smoking or long-term exposure to irritants or pollutants. As the disease progresses, the alveoli are destroyed, reducing the lungs' ability to take in oxygen. Symptoms start mild but worsen over time, ultimately causing severe shortness of breath and respiratory failure if left untreated. Treatment focuses on quitting smoking, medications, surgery, pulmonary rehabilitation, and managing symptoms.
Bronchiectasis
Bronchiectasis
A condition characterized by chronic permanent dilation & destruction of bronchi due to destructive changes in the elastic and muscular layers of bronchial walls.
The common thread in the pathogenesis of bronchiectasis consists of difficulty clearing secretions & recurrent infections with a “vicious circle” of infection and inflammation resulting in airway injury and remodelling.
PLEASE REFER TO REFERENCE TEXTBOOKS FOR CLARITY.
Dyspnea
This document defines and discusses dyspnea (shortness of breath) and cyanosis (blue discoloration of the skin). It outlines the mechanisms, causes, and characteristics of dyspnea associated with respiratory, cardiac, and other medical conditions. Key signs and symptoms that may suggest pulmonary or cardiac origins of dyspnea are provided. The document also defines and describes peripheral and central cyanosis, listing various conditions that can cause each type.
Empyema
This document discusses empyema, which is an accumulation of thick, purulent fluid in the pleural space caused by bacterial pneumonia, lung abscess, chest trauma, or surgery. Common organisms include Staphylococcus aureus and Streptococcus pneumoniae. Empyema develops from a parapneumonic effusion through exudative, fibrino-purulent, and organizing stages. Symptoms include fever, chest pain, and dyspnea. Diagnosis involves imaging and culture of pleural fluid. Treatment requires drainage of fluid, antibiotics for 10-14 days intravenously or longer orally, and oxygen. Nursing diagnoses relate to impaired gas exchange, acute pain, and risk for activity intolerance.
Bronchectasis
Bronchiectasis is a chronic lung disease defined by irreversible dilation of the bronchi. It develops from an initial event that impairs mucociliary clearance, allowing bacteria to colonize and further damage the lungs. The hallmark symptoms are a chronic cough and sputum production lasting months to years. Risk factors include cystic fibrosis, infections, immunodeficiencies, and exposures to toxic substances. Management involves antibiotics, airway clearance techniques, and supplemental oxygen. Severe cases may require surgery.
Complications of pulmonary tb
This document discusses the various complications that can arise from tuberculosis (TB). It outlines local complications affecting the lungs including tuberculomas, cavities, scarring, bronchiectasis, and aspergillomas. It also discusses airway complications such as stenosis. Vascular issues like hemoptysis are reviewed. Mediastinal complications including lymphadenitis and fistulas are summarized. Pleural issues such as empyema and pneumothorax are covered. Finally, chest wall TB and spondylitis are mentioned as extrathoracic complications. Recognition of these sequelae is important for diagnosis and treatment of TB.
Respiratory failure
Respiratory failure occurs when the lungs fail to effectively oxygenate the blood or remove carbon dioxide. It can be caused by conditions that decrease lung function or increase oxygen needs. Symptoms include shortness of breath, confusion, and bluish skin. Diagnosis involves assessing symptoms, risk factors, and tests like blood gases, imaging, and pulmonary function tests. Management focuses on treating the underlying cause, correcting gas exchange abnormalities through oxygen supplementation or ventilation, and preventing complications. Nursing care monitors the patient's condition and provides interventions to address issues like impaired gas exchange, low cardiac output, poor nutrition, and anxiety.
Acute respiratory distress syndrome (ARDS)
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by rapid onset of severe breathing difficulties, low oxygen levels in the blood, and diffuse pulmonary infiltrates leading to respiratory failure. It has three phases: exudative, proliferative, and fibrotic. ARDS can develop due to various causes like pneumonia, sepsis, trauma, inhalation of toxic substances. Diagnosis involves chest x-ray findings and low oxygen levels with normal pulmonary artery pressure. Treatment focuses on treating the underlying cause, providing oxygen supplementation, respiratory support through mechanical ventilation, and managing complications.
Bronchiectasis BSC.pdf
Bronchiectasis is a chronic lung condition characterized by abnormal, permanent dilation of the bronchi and bronchioles. It is most commonly caused by recurrent lung infections that destroy the airways over time. The main symptoms include a persistent cough with sputum production, respiratory infections, hemoptysis, dyspnea, and nail clubbing in severe cases. Diagnosis is made through chest imaging such as high-resolution CT scan that shows the dilated airways. Treatment involves controlling infections with antibiotics, clearing secretions through chest physiotherapy, treating any underlying causes, and surgery in rare cases of localized disease. Complications can include recurrent pneumonia, lung abscesses, and respiratory failure in advanced cases.
Respiratory system 1
This document discusses the pathophysiology, clinical presentation, diagnosis, and treatment of various respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, lung abscess, empyema, pleural effusion, and pneumothorax. It describes the inflammatory processes, risk factors, symptoms, and management approaches for each condition. Diagnostic tests include chest x-rays, pulmonary function tests, arterial blood gases, and sputum/fluid analysis. Treatment involves identifying causative agents, administering appropriate antibiotics and bronchodilators, draining fluid collections, and managing complications like respiratory failure.
More Related Content
What's hot
Cystic Lung Diseases
The document provides an overview of cystic lung diseases and discusses a systematic approach to evaluating cystic lung lesions on CT scans. It begins by defining pulmonary cysts and differentiating them from cavities. It then categorizes cysts based on their location, number, distribution, and associated CT findings. The document outlines a 5-question approach to systematically evaluate cystic lung lesions: 1) Are they true cysts? 2) Are cysts subpleural? 3) Are cysts solitary or multifocal without other findings? 4) Are cysts associated with nodules? 5) Are cysts associated with ground glass opacities? It then provides examples of specific diseases that present with various cyst patterns, such as
Ppt atelectasis
Atelectasis is a collapse or closure of the alveoli in the lungs resulting in reduced or absent ventilation of those areas. It can be caused by obstruction of the airways or pressure on the outside of the lungs. Risk factors include recent surgery, lung disease, premature birth, or confinement to bed. Symptoms include shortness of breath, cough, and low oxygen levels. Treatment focuses on resolving the underlying cause and techniques to reopen the collapsed areas such as bronchodilators, chest physiotherapy, positioning, and sometimes surgery. Nursing care involves monitoring breathing and oxygen levels, encouraging deep breathing and coughing exercises, and preventing complications like pneumonia.
Bronchiectasis
Bronchiectasis in children is an irreversible dilation of the airways caused by destructive changes to the airway walls. It has many causes including cystic fibrosis, infections, immunodeficiencies, and anatomical defects. The pathology involves a vicious cycle of impaired mucus clearance leading to recurrent infections, inflammation, and further airway damage. Symptoms include cough, sputum production, and breathing difficulties. Diagnosis is made through imaging like HRCT that shows changes to airway contours. Treatment focuses on airway clearance techniques and controlling infections with antibiotics. Management of underlying conditions and lung transplantation may be needed in severe cases.
Pulmonary fibrosis
Pulmonary fibrosis involves the replacement of lung tissue by fibrous tissue, reducing lung volume and altering texture so that ventilation cannot take place. It increases lung recoil pressure and work of breathing. There are three main types: replacement, focal, and interstitial fibrosis. Idiopathic pulmonary fibrosis (IPF) is a disorder of unknown cause characterized by bilateral, progressive interstitial fibrosis with a histological pattern of usual interstitial pneumonia. It typically affects older adults and has a poor prognosis. Symptoms include a dry cough and dyspnea. Investigations show reticulation on chest imaging and restrictive lung function. Treatment is difficult and lung transplantation is the only definitive option.
Lung abscess
This document discusses lung abscesses, which occur when microbial infection causes necrosis and cavitation of lung tissue. There are two main types: primary lung abscesses arise from aspiration of oral bacteria and usually affect middle-aged men with risk factors like alcoholism or gastroesophageal reflux; secondary lung abscesses have an underlying cause like obstruction or immunosuppression. Symptoms include fever, cough, and chest pain. Diagnosis involves chest imaging like x-ray or CT scan. Primary abscesses are generally treated with antibiotics like clindamycin or beta-lactam combinations for 3-14 weeks. Secondary abscesses require treatment of the underlying condition as well as antibiotics targeting the identified pathogen. Complications can include recurrence,
Pneumothorax
This document discusses pneumothorax, beginning with a definition and overview of types including spontaneous, traumatic, and tension pneumothorax. Risk factors are identified such as male sex, smoking, age, genetics, and lung disease. Diagnosis involves physical exam findings and imaging tests like chest x-ray and CT scan. Treatment goals are promoting lung expansion and eliminating causes, using methods such as aspiration, tube drainage, or surgery. Complications are also reviewed.
atelectasis
Atelectasis is the collapse or closure of part or all of the lung resulting in reduced gas exchange. It can be primary, due to prematurity or lung immaturity, or secondary due to obstruction from mucus, tumors, or surgery. Symptoms include rapid shallow breathing, cough, hypoxia, and fever. Diagnosis involves chest x-ray, sputum tests, and CT scans. Treatment focuses on positioning, suctioning mucus, oxygen therapy, and preventing infections. Nursing care manages breathing, airway clearance, gas exchange, and monitors for complications like infections.
13 respiratory failure
The document discusses respiratory failure, including its definition, classification, causes, mechanisms, clinical manifestations, diagnosis and treatment. It defines respiratory failure as a clinical syndrome caused by conditions severely affecting the lung's ability to oxygenate blood or eliminate carbon dioxide. Treatment involves identifying and managing the underlying cause, ensuring an open airway, providing oxygen therapy, and mechanical ventilation if needed.
Chronic bronchitis
Chronic bronchitis is defined as a persistent cough with mucus production for at least three months in a year for two consecutive years. It is primarily caused by long-term irritation and inflammation of the airways due to cigarette smoke or other inhaled chemicals. Chronic bronchitis can progress to more severe lung diseases like COPD or lung cancer and, if left untreated, may result in heart failure or respiratory infections. The pathology involves damage to the airways, thickening of the mucus membranes, and increased mucus production.
Respiratory failure
Respiratory failure occurs when the lungs fail to effectively oxygenate the blood or remove carbon dioxide. It is classified as type 1 (hypoxic but normal CO2 levels) or type 2 (hypoxic and elevated CO2 levels). Type 1 is more common and caused by conditions like pneumonia that affect only part of the lungs. Type 2 involves more generalized lung damage. Acute respiratory failure develops rapidly while chronic failure progresses over days or longer. Treatment depends on the underlying cause but may include supplemental oxygen, mechanical ventilation, treating infection, or lung transplantation in severe cases.
Copd 2012 pdf
This document discusses chronic obstructive pulmonary disease (COPD). It defines COPD as a common lung disease characterized by persistent airflow limitation. The document covers COPD epidemiology, risk factors, pathology, clinical features, investigations, management, and treatment options. Management involves smoking cessation, bronchodilators, inhaled corticosteroids, vaccinations, oxygen therapy, and pulmonary rehabilitation.
Emphysema ppt
Emphysema is a lung disease that causes damage to the air sacs in the lungs called alveoli, resulting in shortness of breath. It is usually caused by smoking or long-term exposure to irritants or pollutants. As the disease progresses, the alveoli are destroyed, reducing the lungs' ability to take in oxygen. Symptoms start mild but worsen over time, ultimately causing severe shortness of breath and respiratory failure if left untreated. Treatment focuses on quitting smoking, medications, surgery, pulmonary rehabilitation, and managing symptoms.
Bronchiectasis
Bronchiectasis
A condition characterized by chronic permanent dilation & destruction of bronchi due to destructive changes in the elastic and muscular layers of bronchial walls.
The common thread in the pathogenesis of bronchiectasis consists of difficulty clearing secretions & recurrent infections with a “vicious circle” of infection and inflammation resulting in airway injury and remodelling.
PLEASE REFER TO REFERENCE TEXTBOOKS FOR CLARITY.
Dyspnea
This document defines and discusses dyspnea (shortness of breath) and cyanosis (blue discoloration of the skin). It outlines the mechanisms, causes, and characteristics of dyspnea associated with respiratory, cardiac, and other medical conditions. Key signs and symptoms that may suggest pulmonary or cardiac origins of dyspnea are provided. The document also defines and describes peripheral and central cyanosis, listing various conditions that can cause each type.
Empyema
This document discusses empyema, which is an accumulation of thick, purulent fluid in the pleural space caused by bacterial pneumonia, lung abscess, chest trauma, or surgery. Common organisms include Staphylococcus aureus and Streptococcus pneumoniae. Empyema develops from a parapneumonic effusion through exudative, fibrino-purulent, and organizing stages. Symptoms include fever, chest pain, and dyspnea. Diagnosis involves imaging and culture of pleural fluid. Treatment requires drainage of fluid, antibiotics for 10-14 days intravenously or longer orally, and oxygen. Nursing diagnoses relate to impaired gas exchange, acute pain, and risk for activity intolerance.
Bronchectasis
Bronchiectasis is a chronic lung disease defined by irreversible dilation of the bronchi. It develops from an initial event that impairs mucociliary clearance, allowing bacteria to colonize and further damage the lungs. The hallmark symptoms are a chronic cough and sputum production lasting months to years. Risk factors include cystic fibrosis, infections, immunodeficiencies, and exposures to toxic substances. Management involves antibiotics, airway clearance techniques, and supplemental oxygen. Severe cases may require surgery.
Complications of pulmonary tb
This document discusses the various complications that can arise from tuberculosis (TB). It outlines local complications affecting the lungs including tuberculomas, cavities, scarring, bronchiectasis, and aspergillomas. It also discusses airway complications such as stenosis. Vascular issues like hemoptysis are reviewed. Mediastinal complications including lymphadenitis and fistulas are summarized. Pleural issues such as empyema and pneumothorax are covered. Finally, chest wall TB and spondylitis are mentioned as extrathoracic complications. Recognition of these sequelae is important for diagnosis and treatment of TB.
Respiratory failure
Respiratory failure occurs when the lungs fail to effectively oxygenate the blood or remove carbon dioxide. It can be caused by conditions that decrease lung function or increase oxygen needs. Symptoms include shortness of breath, confusion, and bluish skin. Diagnosis involves assessing symptoms, risk factors, and tests like blood gases, imaging, and pulmonary function tests. Management focuses on treating the underlying cause, correcting gas exchange abnormalities through oxygen supplementation or ventilation, and preventing complications. Nursing care monitors the patient's condition and provides interventions to address issues like impaired gas exchange, low cardiac output, poor nutrition, and anxiety.
Acute respiratory distress syndrome (ARDS)
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by rapid onset of severe breathing difficulties, low oxygen levels in the blood, and diffuse pulmonary infiltrates leading to respiratory failure. It has three phases: exudative, proliferative, and fibrotic. ARDS can develop due to various causes like pneumonia, sepsis, trauma, inhalation of toxic substances. Diagnosis involves chest x-ray findings and low oxygen levels with normal pulmonary artery pressure. Treatment focuses on treating the underlying cause, providing oxygen supplementation, respiratory support through mechanical ventilation, and managing complications.
What's hot (20)
Similar to Bronchiectasis.ppt
Bronchiectasis BSC.pdf
Bronchiectasis is a chronic lung condition characterized by abnormal, permanent dilation of the bronchi and bronchioles. It is most commonly caused by recurrent lung infections that destroy the airways over time. The main symptoms include a persistent cough with sputum production, respiratory infections, hemoptysis, dyspnea, and nail clubbing in severe cases. Diagnosis is made through chest imaging such as high-resolution CT scan that shows the dilated airways. Treatment involves controlling infections with antibiotics, clearing secretions through chest physiotherapy, treating any underlying causes, and surgery in rare cases of localized disease. Complications can include recurrent pneumonia, lung abscesses, and respiratory failure in advanced cases.
Respiratory system 1
This document discusses the pathophysiology, clinical presentation, diagnosis, and treatment of various respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, lung abscess, empyema, pleural effusion, and pneumothorax. It describes the inflammatory processes, risk factors, symptoms, and management approaches for each condition. Diagnostic tests include chest x-rays, pulmonary function tests, arterial blood gases, and sputum/fluid analysis. Treatment involves identifying causative agents, administering appropriate antibiotics and bronchodilators, draining fluid collections, and managing complications like respiratory failure.
Respiratory Distress in Newborns
This document discusses respiratory distress in newborns, listing common medical and surgical causes such as transient tachypnea of the newborn (TTNB), respiratory distress syndrome (RDS), meconium aspiration syndrome, and pneumothorax. It then focuses on the pathophysiology, clinical presentation, diagnosis, and management of TTNB, RDS, and meconium aspiration syndrome. TTNB is usually mild and self-limited, resolving within 3 days with supportive care. RDS is caused by surfactant deficiency and presents with progressive respiratory distress, responding well to surfactant replacement therapy. Meconium aspiration syndrome involves airway obstruction and inflammation from aspirated meconium, often
SESSION 14. Lung abscess Bronchiectasis.pptx
The document discusses lung abscess and bronchiectasis. It defines lung abscess as a suppurative lesion caused by infected lung tissue necrosis that forms cavities containing pus or fluid. Bronchiectasis is an abnormal, permanent dilation of the bronchi often caused by infection. The document outlines the epidemiology, pathogenesis, clinical features, investigations, management, and prevention of lung abscess and bronchiectasis. It describes the most common causes and pathogens, as well as signs and symptoms, management with antibiotics and drainage, and importance of preventing aspiration to control the conditions.
7 SUPPURATIVE LUNG DISEASES.pptx88888888888
This document provides information on suppurative lung diseases including bronchiectasis, lung abscess, and empyema. It discusses their causes, pathophysiology, clinical presentation, investigations, and treatment. Bronchiectasis is chronic dilatation of the bronchi caused by infection and inflammation. Lung abscess refers to localized suppuration in the lung associated with cavity formation. Empyema is the collection of pus within the pleural cavity, usually arising from bacterial spread from pneumonia or lung abscess rupture. Management involves drainage, antibiotics, and sometimes surgery.
Pulmonary Abscess in Children .. Dr Padmesh
This document discusses pulmonary abscesses in children. It defines a lung abscess as a localized collection of thick-walled purulent material within the lung parenchyma caused by infection and tissue destruction. Lung abscesses can be primary, occurring in previously healthy patients, or secondary, occurring in patients with underlying conditions. Common predisposing factors include aspiration, pneumonia, cystic fibrosis, and immunosuppression. Symptoms include cough, fever, dyspnea, and chest pain. Diagnosis involves chest X-ray and CT scan identifying a cavity containing air-fluid levels. Treatment consists of antibiotics for 2-3 weeks, with surgical drainage for severe or unimproving cases. Prognosis is generally excellent.
pulmonary Lung Abscess.pptx
This document discusses pulmonary abscesses in children. It defines a lung abscess as a localized collection of thick-walled purulent material within the lung parenchyma caused by infection and tissue destruction. Lung abscesses can be primary, occurring in previously healthy patients, or secondary, occurring in patients with underlying conditions. Common predisposing factors include aspiration, pneumonia, cystic fibrosis, and immunosuppression. Symptoms include cough, fever, dyspnea, and chest pain. Diagnosis involves chest x-ray or CT scan identifying a cavity containing air-fluid levels. Treatment consists of antibiotics for 2-3 weeks, with surgical drainage for severe or unimproving cases. Prognosis is generally excellent.
Croup
Heterogeneous group of illnesses affecting larynx, trachea and bronchi.
Laryngotracheitis, LTB, laryngotracheo-bronchopneumonitis and spasmodic croup are inclusive.
Upper airway obstruction in croup causes :
A barking cough, hoarse voice, inspiratory stridor and variable respiratory distress.
PARA PNEUMONIC EFFUSION
This document discusses parapneumonic effusions (PPE), which are pleural effusions caused by pneumonia. It classifies PPEs as uncomplicated, complicated, or empyema thoracis based on presence of bacteria or pus. Uncomplicated PPEs resolve with antibiotics but complicated PPEs and empyemas require drainage via thoracentesis or chest tube. The document outlines signs, investigations, treatment including antibiotics and drainage procedures, and surgical options like VATS for managing PPEs.
REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..
This document summarizes community acquired pneumonia, its types , causes, organisms, CRUB-65 score, difference with atypical pneumonia, investigations, treatment and prevention.
ppe-130802100208-phpapp02 (1).pdf
A parapneumonic effusion is a type of pleural effusion caused by pneumonia. It can be uncomplicated, complicated, or develop into an empyema. Uncomplicated effusions resolve with antibiotics but complicated effusions require drainage in addition to antibiotics. Empyemas contain frank pus in the pleural space. Treatment involves selecting appropriate antibiotics, evaluating if pleural fluid drainage is needed based on fluid analysis and imaging findings, and considering intrapleural thrombolytics, tube thoracostomy, or surgery if drainage is ineffective or the patient does not improve.
Acute inflammations-of-larynx
This document discusses various acute inflammations of the larynx including acute laryngitis, acute epiglottitis, acute laryngotracheobronchitis, laryngeal diphtheria, and edema of the larynx. It describes the etiology, clinical features, investigations, and treatment for each condition. Viruses and bacteria are common causes and may result in hoarseness, pain, difficulty swallowing, and airway obstruction in severe cases. Treatment involves antibiotics, steroids, humidified oxygen, intubation or tracheostomy if needed.
Pneumothorax
This document discusses pneumothorax, including causes, symptoms, diagnosis, and treatment. It defines pneumothorax as air in the pleural cavity, causing lung collapse. Common causes include spontaneous pneumothorax, trauma, and medical procedures. Symptoms range from minimal to severe dyspnea. Chest x-ray and CT scan are used to diagnose and estimate size. Treatment depends on severity but may include observation, needle aspiration, chest tube drainage, pleurodesis, or surgery. Recurrence risk varies from 36-83% without treatment to 0.6-2% after surgery.
intussusceptIon
Intussusception is a condition where one segment of the bowel slides into an adjacent segment, like a telescope. It most commonly occurs in young children under 2 years old and presents with abdominal pain, vomiting, and bloody stools. Diagnosis can be made with abdominal ultrasound or CT scan which show target or doughnut signs. Initial treatment involves rehydration and non-operative reduction with air or barium enema. If non-operative measures fail or complications exist, surgical reduction is required to prevent bowel obstruction or ischemia.
COPD
COPD is a progressive lung disease characterized by persistent airflow obstruction. It is an umbrella term used to describe conditions such as emphysema, chronic bronchitis, asthma, and others. Emphysema involves abnormal enlargement of the air spaces in the lungs and destruction of their walls. Major risk factors include smoking, air pollution, and genetic conditions. Chronic bronchitis involves inflammation of the airways and increased mucus production, often due to smoking. Asthma is a chronic inflammatory disorder of the airways causing recurrent wheezing and shortness of breath. Bronchiectasis results from destruction of the bronchial walls due to recurring infections. The document provides details on the pathogenesis, morphology, and clinical features of these
ACUTE & CHRONIC RHINOSINUSITIS
1. Rhinosinusitis is inflammation of the nose and paranasal sinuses that can be acute or chronic. Acute sinusitis lasts less than 4 weeks while chronic lasts over 12 weeks.
2. Common causes include viral, bacterial, and fungal infections. Bacteria like Streptococcus pneumoniae and Haemophilus influenzae often cause acute bacterial rhinosinusitis.
3. Symptoms depend on the involved sinus but may include nasal congestion, facial pain, headache, and fever. Diagnosis involves medical history, exam, and imaging tests like x-ray or CT scan of the sinuses.
Bilateral hyperlucent hemithorax
SHORT TALK ABOUT DIFFERENTIAL DIAGNOSIS BILATERAL HYPERLUCENT LUNGS , COMMON AND LESS COMMON CAUSES WITH CLUES TO DIAGNOSIS AND SOME EXAMPLES
HOPPING YOU LIKE IT
DR HISHAM ALKHATIB
CONSULTANT RADIOLOGIST
Bronciectasis
Bronchiectasis is permanent dilation of the bronchi and bronchioles due to destruction of muscle and elastic tissue, usually resulting from chronic necrotizing infections. It is characterized by a persistent cough and expectoration of copious amounts of purulent sputum. Predisposing factors include bronchial obstruction from foreign bodies or infection, congenital conditions like cystic fibrosis, and immunodeficiency states that increase susceptibility to repeated lung infections. Chronic infection and obstruction cause damage and dilation of the bronchial walls over time in a recurrent cycle. On microscopy, areas of ulceration and inflammation are seen within the bronchial walls in active disease, and fibrosis develops in chronic cases.
Laryngeal infections
This document discusses laryngeal infections. It begins by introducing laryngitis as an inflammation of the larynx that can be acute or chronic. Acute laryngitis is usually self-limited while chronic lasts over 3 weeks. Causes include vocal misuse, noxious agents, and viruses or bacteria. In children, important acute laryngeal infections are epiglottitis, croup, and bacterial laryngotracheobronchitis. Chronic laryngitis can be caused by repeated acute infections or long-term irritants like smoking. Diagnosis involves examination and investigations depend on the suspected infection. Management involves treating the underlying cause, antibiotics, corticosteroids, and occasionally intubation or tracheostomy
Bronchiactasis - Lecture by Dr. Nasir Farooq Butt.pptx
This document discusses a case of a 28-year-old male smoker who presented with a 2-year history of cough and sputum production. On examination, he had clubbing and crackles in his lungs. The document then provides an in-depth discussion of bronchiectasis including its definition, pathophysiology, causes, clinical features, diagnosis, management, and complications. Cystic fibrosis is also discussed as an important cause of bronchiectasis.
Similar to Bronchiectasis.ppt (20)
Bronchiactasis - Lecture by Dr. Nasir Farooq Butt.pptx
Bronchiactasis - Lecture by Dr. Nasir Farooq Butt.pptx
More from DrYaqoobBahar
radiologicmimicsofcirrhosis-161222165901.pdf
1. The document discusses conditions other than cirrhosis that can result in diffuse surface nodularity of the liver or portal hypertension such as chronic Budd-Chiari syndrome, chronic portal vein thrombosis, sarcoidosis, and pseudocirrhosis of treated breast cancer metastases or fulminant hepatic failure.
2. It provides imaging examples and characteristics of these non-cirrhotic conditions that can mimic cirrhosis on imaging. For example, pseudocirrhosis of treated breast cancer metastases shows diffuse hepatic nodularity and signs of portal hypertension but the history of breast cancer and prior imaging helps identify the correct diagnosis.
3. Nodular regenerative hyperplasia, congenital hepatic fibrosis, and
usglivercirrhosis-190918135350.pdf important
This document summarizes ultrasound findings for cirrhosis of the liver. Key findings include coarse echotexture and nodular surface of the liver. Regenerating nodules appear isoechoic or hypoechoic. Portal hypertension is a complication and is evidenced by dilated portal veins, low portal flow, and portosystemic collaterals visible on ultrasound. Doppler ultrasound can detect changes in portal flow from normal hepatopetal to reversed hepatofugal flow in advanced cases.
C.08a-Diagnosis-and-Treatment-of-Acute-Ischemic-Stroke-Presentation-ppt.pptx
1. The document discusses the diagnosis and treatment of acute ischemic stroke. It outlines the time windows for treatment with intravenous thrombolysis, which is most effective within 4.5 hours of symptom onset.
2. Early diagnosis is critical in stroke care due to the concept of "time is brain". Delays in treatment can lead to further neuronal damage and worse outcomes. The goals are to perform a CT scan within 20 minutes of arrival and initiate thrombolysis within 60 minutes.
3. Post-thrombolytic management focuses on monitoring for hemorrhagic complications and providing supportive care to reduce disability from the stroke.
hepaticcoma.pdf is important for medical students
Hepatic coma is an advanced complication of liver failure characterized by reversible decreased neurologic function and loss of consciousness due to the liver's failure to detoxify toxic substances. It is caused by chronic liver disease, fulminant hepatic failure, or portosystemic shunts. Patients experience disturbances in consciousness, neurological signs, and mental changes. Treatment focuses on treating the underlying cause, decreasing ammonia production, and controlling risk factors through supportive care, lactulose, rifaximin, and L-ornithine/L-aspartate supplementation. Complications can include brain herniation, organ failure, and brain edema.
abdominaltuberculosis-181221163344.asddfpdf
1) Abdominal tuberculosis poses a diagnostic challenge due to its nonspecific symptoms. It is increasingly common and can involve the gastrointestinal tract, peritoneum, lymph nodes or solid organs.
2) Tubercle bacilli typically spread from the lungs or ingested materials to the abdominal cavity via the bloodstream or lymphatics. This can cause caseating granulomas and lesions in the abdomen.
3) Common presentations include abdominal pain, fever, weight loss, and ascites or abdominal masses. Imaging shows lymphadenopathy, bowel thickening or strictures, and ascites. Diagnosis relies on clinical suspicion plus histology, microbiology or response to antitubercular treatment.
imaginginabdominaltb-150913151714-lva1-app6891.pdf
- Abdominal tuberculosis can affect the peritoneum, gastrointestinal tract, abdominal lymph nodes, and solid organs like the liver, pancreas, and spleen. It is most commonly seen in the ileoceal region.
- On imaging, tubercular peritonitis can appear as wet ascites, fibrotic omental thickening, or dry adhesions. Lymphadenopathy often shows peripheral rim enhancement.
- Gastrointestinal tuberculosis frequently involves the terminal ileum and cecum, appearing as thickened valves, contracted cecum, or strictures on barium studies or CT.
Diagnosis and managment of pulmonary embolism
A pulmonary embolism is a sudden blockage in a lung artery, usually caused by a blood clot breaking off and traveling to the lungs. PE is a common cause of death in hospitalized patients. Risk factors include genetic mutations, cancer, obesity, smoking, and surgery. Symptoms may include dyspnea, chest pain, and cough. Diagnosis involves assessing risk factors, blood tests, imaging like CT scans, and echocardiograms. Treatment involves immediate anticoagulation with blood thinners, potentially thrombolytic therapy for severe cases, and inferior vena cava filters for high-risk patients. Anticoagulation may continue for several months depending on the underlying cause of clotting.
peripartumcardiomyopathy-171026091036.pptx
This document discusses peripartum cardiomyopathy, which is a type of dilated cardiomyopathy of unknown origin that presents with left ventricular systolic dysfunction. It can occur in 1 in 4,000 live births in the United States. The precise causes are unclear but may involve viral infection, immune response abnormalities, or prolonged use of tocolytics. Symptoms include dyspnea, chest pain, and edema. Diagnosis involves excluding other potential causes through ECG, echocardiogram, biomarkers and imaging. Treatment focuses on heart failure medications, anticoagulants if needed, and assisted devices. Prognosis is generally good with 50% fully recovering but risks include persistent symptoms or progression to heart failure.
heartfailure-181102160805.pdf
Heart failure is a clinical syndrome where the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. It can be caused by structural or functional defects in the heart. The most common causes are coronary artery disease, high blood pressure, and diabetes. While it affects about 2% of adults globally, the risk increases to 6-10% for those over age 65. Treatment involves controlling underlying causes, removing precipitating factors, and managing symptoms through diuretics, ACE inhibitors, beta blockers, and other medications.
Pulmonary edema.pptx
Pulmonary edema refers to excess fluid accumulation in the lungs. It can be caused by increased hydrostatic pressure, permeability changes, or a mix of both. Common causes include heart failure, fluid overload, near drowning, trauma, and certain drugs. Symptoms include shortness of breath, cough, wheezing, and anxiety. Diagnosis involves physical exam, imaging like chest x-rays, and tests to check for underlying conditions. Treatment focuses on addressing the underlying cause, giving oxygen, diuretics, and other medications to reduce fluid buildup. Ventilatory support may be needed in severe cases.
Pulmonary edema.pptx
Pulmonary edema refers to excess fluid accumulation in the lungs. It has four main categories based on pathophysiology: increased hydrostatic pressure, interstitial edema, alveolar flooding, and permeability edema. Causes include heart failure, mitral regurgitation, near-drowning, and renal failure. Symptoms include difficulty breathing, cough, and anxiety. Diagnosis involves clinical exam, BNP levels, chest x-ray, and echocardiogram. Treatment focuses on addressing the underlying cause with oxygen, diuretics, nitrates, and sometimes ventilation support.
variceal bleeding 2.pdf
1. Acute variceal hemorrhage refers to bleeding from enlarged veins (varices) in the esophagus or stomach that is caused by portal hypertension from liver cirrhosis. Variceal bleeding is a severe complication and is the cause of bleeding in 70% of upper GI bleeds in cirrhotic patients.
2. Varices develop due to increased pressure in the portal vein system from cirrhosis. Once varices form, there is a risk of 15% annual bleeding for large varices. Bleeding can often be controlled with medical and endoscopic therapy but there is a high risk (60%) of rebleeding without intervention.
3. Varices are classified based on location
Hypertensive emergency.pptx
Hypertension emergencies require rapid reduction of blood pressure to prevent end organ damage. Hypertensive urgency can be managed as an outpatient but emergencies require hospitalization. Initial evaluation assesses for signs of damage to heart, kidneys, brain, or vasculature. Parenteral drugs like nicardipine, labetalol, and esmolol are used to lower blood pressure 10-15% within 1 hour and further to 160/100 mmHg in 2-6 hours, with goals tailored to specific conditions like stroke, heart failure, or aortic dissection. Oral agents like clonidine or nifedipine may be used after initial parenteral treatment to control blood pressure before discharge
Hypertensive emergency.pptx
Hypertension emergencies require rapid reduction of blood pressure to prevent end organ damage. Hypertensive urgency can be managed as an outpatient with oral medications, while emergencies require hospitalization and intravenous drugs. Initial evaluation assesses for signs of heart, brain, kidney and vascular damage. Parenteral drugs like nicardipine, labetalol and esmolol are used but sodium nitroprusside is no longer first-line due to risks. Treatment goals depend on the specific organ involved and reduce pressure by 10-25% within 1-2 hours.
myxedemacoma-181130040149.pdf
1) Myxedema coma is a rare life-threatening condition that occurs when a patient with severe, long-standing hypothyroidism experiences physiological decompensation, usually brought on by an external precipitating event like infection.
2) It is characterized by hypothermia, unconsciousness, decreased metabolism and oxygen consumption. Patients often present with symptoms of both the underlying hypothyroidism and the precipitating condition.
3) Treatment involves supportive care, thyroid hormone replacement, glucocorticoids, and treating any underlying infections or precipitating conditions. Patients require intensive monitoring and care due to involvement of multiple organ systems.
variceal bleeding.pdf
This document discusses portal hypertension and variceal bleeding. It covers the pathophysiology of variceal formation, causes of portal hypertension, detection of varices via endoscopy and other imaging modalities, management of variceal bleeding, and medical therapies to decrease portal pressure including vasopressin analogs, somatostatin analogs, beta-blockers, and other agents. Key points are that variceal bleeding has high mortality, endoscopy is the primary method to detect varices, and drugs like terlipressin and beta-blockers aim to decrease portal pressure and prevent rebleeding.
livervaricealbleeding12-140113002343-phpapp02.pdf
This document discusses gastroesophageal varices, which develop in 55% of cirrhotic patients. It covers the risk factors, signs, diagnosis, and treatment of variceal bleeding, including endoscopic band ligation, TIPS procedure, pharmacologic therapies like beta-blockers, and balloon tamponade. The priority in treatment is stabilizing the patient hemodynamically before diagnostic or therapeutic endoscopy. Recurrence of bleeding remains high, so long-term management is also addressed.
adrenalcrisis-220627010816-f7d5cddb.pdf
This document summarizes adrenal gland function and adrenal insufficiency. It describes:
1) The adrenal glands produce cortisol, aldosterone, and androgens which regulate stress response, electrolyte balance, and sex characteristics.
2) Primary adrenal insufficiency results from adrenal gland dysfunction and causes deficiencies in cortisol, aldosterone, and sex hormones. Secondary adrenal insufficiency is caused by pituitary or hypothalamic disease and causes cortisol deficiency alone.
3) Adrenal crisis is a life-threatening emergency characterized by refractory hypotension that requires aggressive treatment with glucocorticoid replacement such as hydrocortisone.
hypertensiveemergencies-160418043048.pdf
This document defines hypertensive emergencies and discusses their management. It begins by classifying hypertension and defining hypertensive crises. Hypertensive emergencies are acute severe hypertension with signs of target organ damage, while hypertensive urgencies have severe hypertension without organ damage. The document then covers the epidemiology, etiology, pathophysiology, presentation, investigations, and management of hypertensive emergencies. It discusses treating different organ-specific emergencies like stroke, heart failure, and kidney injury. The management involves rapid blood pressure reduction while monitoring for complications. Various intravenous medications are outlined for treating hypertensive emergencies based on the target organ involved.
ild2-160503173013.pdf
This document discusses diffuse parenchymal lung diseases (DPLDs), also called interstitial lung diseases (ILDs). It classifies DPLDs into four main groups and describes some of the most common diseases within each group, including their symptoms, radiologic appearances, and differential diagnoses. Major diseases discussed include sarcoidosis, idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, pneumoconiosis like silicosis, and interstitial lung diseases associated with connective tissue diseases. HRCT is highlighted as a sensitive tool for detecting and characterizing different interstitial lung disease patterns.
More from DrYaqoobBahar (20)
C.08a-Diagnosis-and-Treatment-of-Acute-Ischemic-Stroke-Presentation-ppt.pptx
C.08a-Diagnosis-and-Treatment-of-Acute-Ischemic-Stroke-Presentation-ppt.pptx
imaginginabdominaltb-150913151714-lva1-app6891.pdf
imaginginabdominaltb-150913151714-lva1-app6891.pdf
Recently uploaded
How to Add Chatter in the odoo 17 ERP Module
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...National Information Standards Organization (NISO)
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.How to Manage Your Lost Opportunities in Odoo 17 CRM
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
How to Fix the Import Error in the Odoo 17
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
The History of Stoke Newington Street Names
Presented at the Stoke Newington Literary Festival on 9th June 2024
www.StokeNewingtonHistory.com
CACJapan - GROUP Presentation 1- Wk 4.pdf
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Hindi varnamala | hindi alphabet PPT.pdf
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
DRUGS AND ITS classification slide share
Any substance (other than food) that is used to prevent, diagnose, treat, or relieve symptoms of a
disease or abnormal condition
clinical examination of hip joint (1).pdf
described clinical examination all orthopeadic conditions .
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...Nguyen Thanh Tu Collection
https://app.box.com/s/y977uz6bpd3af4qsebv7r9b7s21935vdRecently uploaded (20)
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
Bronchiectasis.ppt
- 1. BRONCHIECTASIS Presentor : Dr. Habib Shafi Niazi 1401
- 2. INTRODUCTION • Abnormal dilatation of the bronchi. • Irrespective of cause, Chronic suppurative airway infection with: • Sputum production • Progressive scarring • Lung damage
- 3. ETIOLOGY • Congenital • Cystic fibrosis • Ciliary dysfunction syndromes • Primary ciliary dyskinesia (immotile cilia syndrome • Kartagener's syndrome (sinusitis and transposition of the viscera) • Primary hypogammaglobulinaemia
- 4. ETIOLOGY • Acquired: children • Pneumonia (complicating whooping cough or measles) • Primary TB • Inhaled foreign body • Acquired: adults • Suppurative pneumonia • Pulmonary TB • Allergic bronchopulmonary aspergillosis complicating asthma Bronchial tumours
- 6. PATHOLOGY • Cavities may be lined by granulation tissue, squamous epithelium or normal ciliated epithelium • May also be inflammatory changes in the deeper layers of the bronchial wall • hypertrophy of the bronchial arteries. • Chronic inflammatory and fibrotic changes are usually found in the surrounding lung tissue • All this factor results in progressive destruction of the normal lung architecture in advanced cases.
- 7. CLINICAL FEATURES: SYMPTOM • Cough • Chronic productive cough: accumulation of pus in dilated bronchi • Usually worse in mornings and often brought on by changes of posture. • Sputum often copious and persistently purulent in advanced disease • Halitosis is a common accompanying feature • Pneumonia and pleurisy • Due to inflammatory changes in lung and pleura surrounding dilated bronchi when spread of infection occurs • fever, malaise and increased cough and sputum volume • May be associated with pleurisy • Recurrent pleurisy in the same site often occurs
- 8. CLINICAL FEATURES: SYMPTOM • Haemoptysis • Can be slight or massive and is often recurrent. • Usually associated with purulent sputum or an increase in sputum purulence • Can, however, be the only symptom in so-called 'dry bronchiectasis' • Poor general health • When disease is extensive and sputum persistently purulent, • There may be associated weight loss, anorexia, lassitude, low-grade fever, and failure to thrive in children • Digital clubbing is common
- 9. CLINICAL FEATURES: PHYSICAL SIGNS • May be found unilaterally or bilaterally in chest • If the bronchiectatic airways • do not contain secretions, no associated lobar collapse: no abnormal physical signs. • Large amounts of sputum - numerous coarse crackles • Collapse with retained secretions blocking a proximal bronchus may lead to locally diminished breath sounds • Advanced disease may lead to scarring and overlying bronchial breathing. • Acute haemoptysis is an important complication
- 10. INVESTIGATIONS • Radiological examination • Unless very gross, is not usually apparent on a chest X-ray. • Advanced disease, thickened airway walls, cystic bronchiectatic spaces, and associated areas of pneumonic consolidation or collapse may be visible • CT is much more sensitive, and shows thickened dilated airways • Assessment of ciliary function • Ciliary dysfunction syndrome • Time taken for a small pellet of saccharin placed in anterior chamber of the nose to reach the pharynx • should not exceed 20 minutes • Ciliary beat frequency - biopsies
- 11. INVESTIGATIONS • Bacteriological and mycological examination of sputum • In addition to common respiratory pathogens, sputum culture may reveal • Pseudomonas aeruginosa • fungi such as Aspergillus • Various Mycobacteria • Frequent cultures are necessary to ensure appropriate treatment of resistant organisms
- 12. MANAGMENT • Airway patency: inhaled bronchodilators and corticosteroids • Physiotherapy - assist the drainage of excess bronchial secretions – great value both in reducing the amount of cough and sputum – preventing recurrent episodes of bronchopulmonary infection. – Deep breathing followed by forced expiratory manœuvres – Percussion of the chest wall with cupped hands - dislodge sput um – Devices which increase airway pressure • Constant amount (positive expiratory pressure mask) • oscillatory manner (flutter valve) – Optimum duration and frequency • amount of sputum • 5-10 minutes once or twice daily is a minimum
- 13. MANAGMENT • Antibiotic therapy • Appropriate antibiotics • larger doses and longer courses are required • Resolution of symptoms is often incomplete - secondary infection occurs with staphylococci and Gram-negative bacilli • Pseudomonas - more challenging and should be guided by the microbiological sensitivities - intravenous injection or infusion • Ciprofloxacin (250-750 mg 12-hourly) • Ceftazidime (1-2 g 8-hourly) may be required. • Haemoptysis in bronchiectasis often responds to treating the underlying infection • Severe cases percutaneous embolisation of the bronchial circulation by an interventional radiologist
- 14. SURGICAL TREATMENT • Excision of bronchiectatic areas - a small proportion of cases. • Usually young patients in whom the bronchiectasis is unilateral and confined to a single lobe or segment on CT. • Patient where medical treatment proves unsuccessful are also unsuitable for surgery • Either extensive bronchiectasis or coexisting chronic lung disease. • In progressive forms of bronchiectasis, resection of destroyed areas of lung • reservoir of infection • considered as a last resort
- 15. PROGNOSIS • Poor in progressive disease when associated with • Ciliary dysfunction • Cystic fibrosis • Eventually causes respiratory failure. • In other patients the prognosis can be relatively good if • physiotherapy is performed regularly • antibiotics are used aggressively
- 16. PREVENTION • Commonly starts in childhood following • Measles • Whooping cough • Primary tuberculous infection, • It is essential that these conditions receive adequate prophylaxis and treatment. • The early recognition and treatment of bronchial obstruction is also important